Medicine
Mesna 1000 mg/10 mL injection
Mesna 1000 mg/10 mL injection is a generic prescription medicine for intravenous use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Mesna
- Brand
- Sold under the generic name
- Strength
- 1000 mg/10 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 10 mL, 10 vials of 10 mL and 8 more
- Manufacturers
- Gland PharmaIndiaEugiaIndiaBaxter HealthcareFresenius KabiSagent PharmaceuticalsHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R05CB05 Mesna
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 December 1988
- Identifiers
- RxCUI 204870DailyMed set ID a880160b-fa82-453a-a971-29ab897876a7, 49e9c804-9e88-4774-8faf-35bd61b3a8e9, 2a2a526f-636b-7920-4261-6c626f612a2a +4NDC 10019-951, 55150-520, 25021-201 +4Application NDA019884, ANDA220518, ANDA090913 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, multi-dose in 1 box / 10 mL in 1 vial, multi-dose | 55150-520-01 | EugiaIndia | 27 January 2026 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 68083-161-01 | Gland PharmaIndia | 20 December 2017 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 68083-161-10 | Gland PharmaIndia | 20 December 2017 |
| 1 vial in 1 box / 10 mL in 1 vial | 10019-951-05 | Baxter Healthcare | 18 July 2018 |
| 1 vial, multi-dose in 1 box / 10 mL in 1 vial, multi-dose | 10019-953-01 | Baxter Healthcare | 30 December 1988 |
| 10 vial, multi-dose in 1 box / 10 mL in 1 vial, multi-dose | 10019-953-02 | Baxter Healthcare | 30 December 1988 |
| 10 vial, multi-dose in 1 tray / 10 mL in 1 vial, multi-dose | 63323-733-10 | Fresenius Kabi | 5 September 2001 |
| 1 vial, multi-dose in 1 box / 10 mL in 1 vial, multi-dose | 63323-733-11 | Fresenius Kabi | 5 September 2001 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 0143-9260-01 | Hikma Pharmaceuticals | 23 February 2004 |
| 1 vial in 1 carton / 10 mL in 1 vial | 25021-201-10 | Sagent Pharmaceuticals | 1 December 2010 |
| 10 vial in 1 carton / 10 mL in 1 vial | 25021-201-11 | Sagent Pharmaceuticals | 1 December 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 1988 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Mesna 1000 mg/10 mL injection.
Other strengths and forms of Mesna
Clinical summary
Mesna is a cytoprotective agent indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis, among other approved uses. It is available as injection and tablets for intravenous and oral use. MedsAcross supplies Mesna for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MesnaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MESNEX prescribing information (Bamboo US Bidco LCC) · U.S. National Library of Medicine, DailyMed
Need Mesna 1000 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.